002210 — Dongsung Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapSucker Stock

Annual cashflow statement for Dongsung Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-14,079	-4,313	-2,122	-2,074	-7,253
Depreciation
Amortisation
Non-Cash Items	11,099	2,363	1,316	2,530	3,607
Unusual Items
Other Non-Cash Items
Changes in Working Capital	5,891	-3,025	-5,196	-6,851	-8,336
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	5,010	-2,752	-3,883	-4,293	-9,943
Capital Expenditures	-6,922	-2,324	-643	-924	-2,467
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	1,283	-7,376	1,281	-4.15	-4,395
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-5,639	-9,700	638	-928	-6,862
Financing Cash Flow Items	-1.35	72.2	-1,052	0	170
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-3,303	1,232	4,240	7,567	13,510
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-4,015	-11,212	954	2,342	-3,290